These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects. Stelljes M; Specht C; Albring J; Volkmann S; Schlösser V; Pauels HG; Poremba C; Bisping G; Opitz C; Scheffold C; Silling G; Kiehl M; Berdel WE; Kienast J Transplantation; 2007 Feb; 83(3):314-22. PubMed ID: 17297406 [TBL] [Abstract][Full Text] [Related]
28. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Smyth LA; Witt CS; Christiansen FT; Herrmann RP; Hollingsworth PN; Townend DC; Edward E; Dawkins RL Bone Marrow Transplant; 1993 Oct; 12(4):351-5. PubMed ID: 8275034 [TBL] [Abstract][Full Text] [Related]
29. [The role of HLA in bone marrow transplantation]. Harada M; Mori T; Matsuda T Rinsho Ketsueki; 1985 Dec; 26(12):1927-35. PubMed ID: 3914558 [No Abstract] [Full Text] [Related]
30. Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures. Irlé C; Chapuis B; Jeannet M; Kaestli M; Montandon N; Speck B Transplant Proc; 1987 Feb; 19(1 Pt 3):2674-7. PubMed ID: 3547946 [No Abstract] [Full Text] [Related]
31. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073 [TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen genes and allergic disease. Howell WM; Holgate ST Monogr Allergy; 1996; 33():53-70. PubMed ID: 8930926 [No Abstract] [Full Text] [Related]
33. GVHD pathophysiology: is acute different from chronic? Toubai T; Sun Y; Reddy P Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979 [TBL] [Abstract][Full Text] [Related]
34. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. Tutschka PJ; Berkowitz SD; Tuttle S; Klein J Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945 [No Abstract] [Full Text] [Related]
35. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody. Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462 [TBL] [Abstract][Full Text] [Related]
36. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease. Leibnitz RR; Lipsky PE; Thiele DL J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559 [TBL] [Abstract][Full Text] [Related]
37. Limiting dilution analysis of human IL-2 producing T-cell precursors. Determination of hierarchical alloantigenic potential of human leukocyte antigens and evaluation of alloimune responses to single HLA-DP molecules. Jeras M; Delbosc A; Bohinjec M; Tongio MM Pflugers Arch; 2000; 439(3 Suppl):R104-6. PubMed ID: 10653157 [TBL] [Abstract][Full Text] [Related]